How a society gala was used to sell young-blood transfusions to baby boomers desperate to cheat death – “People considering enrolling said they had been told they would have to pay $285,000.“

At STAT's request, eight independent experts reviewed informational packets about the clinical trial, and all sharply criticized the study's marketing, design, and scientific rationale.

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website,

View all posts by Robert Zinn →